Rennova Health, Inc. (RNVA)
Stock Price Chart
Key Info
| Market Cap | 600,000 |
| Revenue (ttm) | 15.99M |
| Net Income (ttm) | -135.90M |
| Shares Out | 9.90B |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Jul 31, 2020 |
| Last Price | $0.0002 |
| Previous Close | $0.0001 |
| Change ($) | 0.0001 |
| Change (%) | 100.00% |
| Day's Open | 0.0001 |
| Day's Range | 0.0001 - 0.0002 |
| Day's Volume | 319,992,495 |
| 52-Week Range | 0.0001 - 0.0004 |
More Stats
| Market Cap | 600,000 |
| Enterprise Value | 20.21M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 9.90B |
| Float | 7.97B |
| EPS (basic) | 65.14 |
| EPS (diluted) | -0.03 |
| FCF / Share | -0.02 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 226 |
| Short Ratio | 0.84 |
| Short % of Float | 8.21% |
| Beta | 53.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 0.04 |
| PB Ratio | n/a |
| Revenue | 15.99M |
| Operating Income | -13.65M |
| Net Income | -135.90M |
| Free Cash Flow | -14.46M |
| Net Cash | -19.61M |
| Net Cash / Share | -0.01 |
| Gross Margin | 7.14% |
| Operating Margin | -85.38% |
| Profit Margin | -1,814.50% |
| FCF Margin | -90.45% |
| ROA | -70.62% |
| ROE | n/a |
| ROIC | 175.90% |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.62 | 3.34 | 0.50 | 0.66 | 0.40 | 0.10 | 0.02 | - | 13.07 | 32.93 |
| Revenue Growth | 38.37% | 570.37% | -24.32% | 64.5% | 300% | 525% | - | - | -60.3% | - |
| Gross Profit | 3.67 | 2.09 | 0.43 | 0.50 | 0.34 | 0.10 | 0.02 | - | 5.20 | 14.01 |
| Operating Income | -16.08 | -22.49 | -5.44 | -3.59 | -4.10 | -2.52 | -1.87 | -2.33 | -7.94 | 1.60 |
| Net Income | -55.20 | -32.61 | -5.16 | -3.31 | -3.93 | -1.43 | -3.13 | -18.47 | -7.90 | 18.10 |
| Shares Outstanding | 2.31 | 0.07 | - | - | - | - | - | - | - | - |
| Earnings Per Share | -47.02 | -452.58 | -6,840.00 | -7,605.00 | -9,540.00 | -3,825.00 | -8,325.00 | -49,320.00 | -22,725.00 | 55,800.00 |
| Operating Cash Flow | -17.71 | -19.86 | -3.57 | -2.43 | -3.84 | -3.11 | -0.07 | -4.89 | -5.54 | -5.06 |
| Capital Expenditures | -1.42 | -0.02 | -0.02 | -0.02 | -0.12 | - | -0.07 | -0.83 | -0.46 | -0.48 |
| Free Cash Flow | -19.14 | -19.88 | -3.58 | -2.45 | -3.96 | -3.11 | -0.14 | -5.72 | -6.00 | -5.54 |
| Cash & Equivalents | 0.18 | 0.21 | 7.52 | 1.81 | 4.04 | 7.82 | 7.78 | 7.30 | 12.49 | 19.27 |
| Total Debt | 15.53 | 12.91 | 0.53 | 0.51 | 0.50 | - | - | - | - | 0.01 |
| Net Cash / Debt | -15.35 | -12.70 | 6.99 | 1.30 | 3.54 | 7.82 | 7.78 | 7.30 | 12.49 | 19.26 |
| Assets | 6.29 | 6.48 | 9.31 | 4.32 | 6.98 | 8.66 | 11.20 | 16.30 | 34.34 | 40.08 |
| Liabilities | 41.07 | 21.37 | 1.37 | 1.39 | 1.28 | 0.58 | 1.79 | 4.37 | 4.31 | 7.15 |
| Book Value | -40.61 | -14.89 | 7.94 | 2.93 | 5.70 | 8.08 | 9.41 | 11.94 | 30.03 | 32.93 |
Company Profile
Company Details
| Full Name | Rennova Health, Inc. |
| Country | United States |
| CEO | Seamus Lagan |
Stock Information
| Ticker Symbol | RNVA |
| Stock Exchange | US OTC |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Unique Identifier | OTCMKTS: RNVA |
Description
Rennova Health, Inc., together with its subsidiaries, engages in the hospital operations in the United States. It operates in two segments, Hospital Operations and Clinical Laboratory Services. The company provides a suite of healthcare related products and services for healthcare providers, patients, and individuals. It also offers diagnostic imaging, radiology, surgery, nuclear medicine, wound care and hyperbaric medicine, intensive care, emergency care, and physical therapy services; and X-ray, mammography, bone densitometry, computed tomography, ultrasound, physical therapy, and laboratory services. In addition, the company provides blood and urine, toxicology, clinical pharmacogenetics, and esoteric testing services. Further, it invests in and develops a suite of software products to its diagnostics business. Additionally, the company owns three hospitals, a physician's office in Tennessee, and a rural clinic in Kentucky. Rennova Health, Inc. was founded in 2005 and is based in West Palm Beach, Florida.